Back to search

Sweden· SE-19540913000011

Postafen 25 mg Tablett

A medicinal product containing meclozine dihydrochloride, registered in Sweden by Campus Pharma AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedPostafen 25 mg TablettATC—REGISTER NO.SE-19540913000011PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Meclozine Dihydrochloride
Manufacturer
Campus Pharma AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19540913000011

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Meclozine dihydrochloride in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meclozine dihydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Agyrax, Postafene
  • Denmark · Postafen
  • Spain · Chiclida
  • Finland · Postafen
  • France · Agyrax, Navidoxine
  • United Kingdom (Northern Ireland) · Sea-Legs, Traveleeze
  • Greece · Emetostop
  • Iceland · Postafen
  • Luxembourg · Agyrax, Postafene
  • Netherlands · Suprimal
  • Norway · Postafen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7eef72c-7de8-4198-b8b7-7390d338ebda
GET /v1/drugs/f7eef72c-7de8-4198-b8b7-7390d338ebda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "19540913000011",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19540913000011",
  "product_doc_link": "https://docetp.mpa.se/LMF/Postafen%20tablet%20SmPC_09001bee807a6ef2.pdf"
}

See everything about meclozine dihydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.